Abraxas Petroleum is an independent energy company primarily engaged in the acquisition, exploration, development and production of oil and gas. The company's oil and gas assets are located in the Permian/Delaware Basin, the Rocky Mountain, and South Texas. The company's properties in the Permian/Delaware Basin region are located in two sub-basins, the Delaware Basin and the Eastern Shelf. The company's properties in the Rocky Mountain region are primarily located in the Williston Basin of North Dakota and Montana. The company's properties in the South Texas region are located along the Edwards trend in DeWitt and Lavaca Counties, TX and the Eagle Ford shale and the Austin Chalk in Atascosa and McMullen Counties, TX.

Achaogen is a biopharmaceutical company engaged in discovering, developing, and commercializing antibacterial treatments against multi-drug resistant (MDR) gram-negative infections. The company develops plazomicin for the treatment of serious bacterial infections, including complicated urinary tract infection (cUTI), blood stream infections and other infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae. The company also develops antibacterial candidate, C-Scape, an orally-administered combination of ceftibuten and clavulanate for oral treatment for patients with cUTI, and acute pyelonephritis, caused by expanded spectrum beta-lactamases-producing Enterobacteriaceae.

Apple Hospitality REIT is a real estate investment trust that invests in real estate, primarily in the lodging sector, in the U.S. The company owns hotels located in urban, suburban and developing markets throughout several states. All of the company's hotels operate under Marriott, Hilton or Hyatt brands. The hotels are operated and managed under separate management agreements with hotel management companies, none of which are affiliated with the company

Athenex is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company has three platforms: its Oncology Innovation Platform, dedicated to the research and development of its proprietary drugs; its Commercial Platform, focused on the sales and marketing of its specialty drugs and the market development of its proprietary drugs; and its Global Supply Chain Platform, dedicated to providing a supply of active pharmaceutical ingredients for its clinical and commercial efforts. The company's clinical pipeline includes: Orascovery, Src Kinase inhibition, T-cell Receptor-engineered T-cells, and arginine deprivation therapy.

Valeant Pharmaceuticals International is a pharmaceutical and medical device company that develops, manufactures, and markets a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices). Co. has two operating and reportable segments: Developed Markets, which focuses in dermatology, neurology, gastrointestinal disorders, and eye health therapeutic; and Emerging Markets, which focuses primarily on branded generics, OTC products, and medical devices.

BlueLinx Holdings is a distributor of building and industrial products. The company operates its distribution business through a network of distribution centers. The company serves various metropolitan areas in the U.S. The company distributes products in two principal categories: structural products and specialty products. Structural products include plywood, oriented strand board, rebar and remesh, lumber, spruce and other wood products primarily used for structural support, walls, and flooring in construction projects. Specialty products include engineered wood products, moulding, siding (including vinyl products), cedar, metal products (excluding rebar and remesh) and insulation.

CASI Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products. The company's primary product and candidates in hematology/oncology include: EVOMELA (Melphalan for Injection), an intravenous formulation of melphalan commercialized in the multiple myeloma treatment setting in the United States; CNCT19, which targets CD19, a B-cell surface protein expressed during all phases of B-cell development and a validated target for B-cell driven hematological malignancies; CID-103, an investigational anti-CD38 monoclonal antibody being developed for the treatment of patients with multiple myeloma.

Corbus Pharmaceuticals Holdings is a clinical stage pharmaceutical company focused on the development and commercialization of therapeutics to treat chronic and serious inflammatory and fibrotic diseases. The company's product, lenabasum, is a synthetic, oral, cannabinoid (CB2 agonist) designed to resolve chronic inflammation and halt fibrotic processes. The company is developing lenabasum to treat systemic sclerosis, dermatomyositis, cystic fibrosis and systemic lupus erythematosus. The company's pipeline also includes CRB-4001, a peripherally-restricted, CB1 inverse agonist designed to treat organ specific fibrotic liver diseases, such as nonalcoholic steatohepatitis.

Corporate Capital Trust is a non-diversified closed-end management investment company. The company mainly focuses on the following investments: senior debt, which generally takes the form of senior secured first lien loans, senior secured second lien loans or senior secured bonds; subordinated debt, which are generally subordinated to senior debt and generally unsecured; structured products, which may include collateralized debt obligations, collateralized bond obligations, collateralized loan obligations, structured notes and credit-linked notes; as well as equity investments. At Dec 31 2016, the company's investment portfolio totaled $4.03 billion and consisted mainly of senior and subordinated debt.

Corvus Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies. The company develops small molecules that are designed to selectively inhibit the binding of immunosuppressive adenosine to either A2A receptors or to A2B receptors. The company's initial product candidate, ciforadenant, is an oral, small molecule antagonist of the A2A receptor for adenosine. The company's second clinical product candidate, CPI-006, is an anti-CD73 monoclonal antibody that is designed to both inhibit the production of adenosine and stimulate various immune cells. The company's third clinical product candidate, CPI-818, is a selective, covalent inhibitor of ITK.

Del Frisco's Restaurant Group is a holding company. Through its subsidiaries, the company develops, owns and operates three restaurants: Del Frisco's Double Eagle Steakhouse (Double Eagle), Del Frisco's Grille (the Grille), and Sullivan's Steakhouse (Sullivan's). Double Eagle's menu includes steaks and a range of other offerings, including lamb, seafood, and side dishes and desserts. The Grille's menu is designed to appeal to business and casual diners and features steaks, various menu items and a selection of wines. Sullivan's is a restaurant with an open kitchen, live music and a bar area.

Dril-Quip designs, manufactures, sells and services drilling and production equipment for use in deepwater, harsh environment and severe service applications. The company's products consist of subsea and surface wellheads, subsea and surface production trees, subsea control systems and manifolds, mudline hanger systems, connectors and associated pipe, drilling and production riser systems, liner hangers, wellhead connectors, diverters and safety valves. The company provides technical advisory assistance during installation of its products, as well as rework and reconditioning services. The company's customers may rent or purchase running tools from the company for use in the installation and retrieval of its products.

Ecolab is a provider of water, hygiene and energy technologies and services. The company's segments include: Global Industrial, which provides water treatment and process applications, and cleaning and sanitizing solutions in the manufacturing, food and beverage processing, chemical, power generation, pharmaceutical and commercial laundry industries; Global Institutional, which provides cleaning and sanitizing products to the foodservice, hospitality, lodging, healthcare, government, education and retail industries; and Global Energy, which serves the process chemicals and water treatment needs of the global petroleum and petrochemical industries in both upstream and downstream applications.

Ellington Residential Mortgaging Real Estate Investment Trust is focused on acquiring, investing in, and managing residential mortgage- and real estate-related assets. The company conducts business through its subsidiaries, EARN OP GP LLC and Ellington Residential Mortgage LP. The company may acquire and mortgage servicing rights, credit risk transfer securities, residential mortgage loans, and other mortgage- and real estate-related assets. The company may also invest in other instruments, including forward-settling To-Be-Announced Agency pass-through certificates, interest rate swaps and swaptions, U.S. Treasury securities, Eurodollar and U.S. Treasury futures, other financial derivatives, and cash equivalents.

Emerald Expositions Events is a holding company. Through its subsidiaries, the company is an operator of business-to-business trade shows in the U.S. The company operates in a number of industry sectors: Gift, Home & General Merchandise; Sports; Design & Construction; Technology; Jewelry; and other trade shows. Each of the company's exhibitions are held at least once per year, and provide a venue for exhibitors to launch new products, develop sales leads and promote their brands. In addition to organizing trade shows and conferences, the company also operates websites and related digital products, and produces publications, each of which is aligned with a specific sector for which it organizes a trade show.

Enbridge is an energy transportation and distribution companyoperating in 5 segments: Liquids Pipelines, consists of common carrier and contract crude oil, natural gas liquids and refined products pipelines and terminals; Gas Distribution, of Co.'s natural gas utility operations; Gas Pipelines and Processi consists of investments in natural gas pipelines and processing facilities; Green Power and Transmission, consists of Co.'s investments in renewable energy assets and transmission facilities; and Energy Services, consist of physical commodity marketing activity and logistical services.

Entercom Communications is a holding company. Through its subsidiaries, Co, is a media and entertainment company primarily engaged in the sale of advertising time to local, regional and national advertisers and national network advertisers who purchase commercials in varying lengths. The company focuses on station-related digital product suites, which allow for audience interaction and participation, and integrated digital advertising solutions. The company's stations are classified by their format, such as news, sports, talk, classic rock, urban, adult contemporary, alternative and country, among others.

Fidus Investment operates as an externally managed, closed-end, non-diversified business development company. The company's investment objective is to provide risk-adjusted returns by generating both current income from its debt investments and capital appreciation from its equity related investments.

Full House Resorts owns, leases, operates, develops, manages, and/or invests in casinos and related hospitality and entertainment facilities. The company manages its casinos based on geographic regions within the U.S. The casino/resort operations includes four segments: the Silver Slipper Casino and Hotel (Hancock County, MI); Bronco Billy's Casino and Hotel (Cripple Creek, CO); the Rising Star Casino Resort (Rising Sun, IN); and the Northern Nevada segment, consisting of the Grand Lodge Casino (Incline Village, NV) and Stockman's Casino (Fallon, NV).

Idera Pharmaceuticals is a biopharmaceutical company. The company utilizes two proprietary drug discovery technology platforms to design and develop drug candidates: Toll-like receptor (TLR); and its nucleic acid. The company's TLR drug candidates are: IMO-2125, an indication for Anti-PD1 Refractory Metastatic Melanoma and Refractory Solid Tumors; and IMO-8400, an indication for Dermatomyositis. The company's Nucleic Acid Chemistry research programs comprised of: IDRA-008, for treatment of Familial Chylomicronemia Syndrome and Familial Partial Lipodystrophy; Nucleic Acid Chemistry Compound, an indication for renal disease; and IMO-9200, an indication for non-malignant Gastrointestinal Disorders.

International Flavors & Fragrances is a creator and manufacturer of taste, scent and complementary adjacent products, including cosmetic active and natural health ingredients. The company's operating segments are Taste and Scent. The Taste segment develops a range of different flavors and taste offerings for its customers, most of which are tailor-made. The company's Taste business is comprised of various portfolios across flavor compounds, savory solutions, inclusions and nutrition and specialty ingredients. The Scent segment creates fragrance compounds and fragrance ingredients for the household and personal care products. The company also produces cosmetic active and functional ingredients for use in cosmetics.

Invitae is engaged in genetic testing services that support patient care throughout life's journey from inherited disease diagnosis, to family planning, to health screening with a network of patients, healthcare providers, biopharma and advocacy partners. The company's tests include genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions. In addition, the company's services also include screening and testing in reproductive health, including preimplantation and carrier screening for inherited disorders, prenatal diagnosis, miscarriage analysis and pediatric developmental disorders.

Invuity is a medical technology company that utilizes its proprietary Intelligent Photonics technology to develop illuminated surgical devices to provide surgeons with illumination and visualization of surgical cavities during access procedures. As of Dec 31 2017, the company marketed six categories of illuminated surgical devices, consisting of over 40 devices, which includes reusable illuminated surgical retractors that include a Photonguide, handheld illuminated aspiration devices and drop-in intracavity illuminators. The company's Photonguides are integrated into these devices to deliver improved visualization of the surgical cavity. The company's accessories include sterilization trays and light cables.

Kingstone Companies is an insurance holding company. Through its wholly-owned subsidiary, Kingstone Insurance Company (KICO), the company provides property and casualty insurance products to individuals and small businesses. KICO is a licensed property and casualty insurance company in New York, New Jersey, Connecticut, Massachusetts, Pennsylvania, Rhode Island, Maine and New Hampshire. The company's product lines include: personal lines, which provide homeowners and dwelling fire multi-peril, cooperative/condominiums and personal umbrella policies; commercial liability, which provides businessowners policies; and livery physical damage, which writes for-hire vehicle physical damage only policies.

Kirkland's is a retailer of home decor in the U.S., operating in stores as well as an e-commerce enabled website, www.kirklands.com. The company's stores present a selection of merchandise, including holiday decor, furniture, art, fragrance and accessories, ornamental wall decor, decorative accessories, mirrors, lamps, textiles, artificial floral products, gifts, housewares, outdoor living items, frames and clocks. The company's stores provides assortment of holiday merchandise during seasonal periods as well as items carried throughout the year suitable for gift-giving. The company provides its customers an engaging shopping experience characterized by merchandise selection reflecting existing styles.

Legacy Reserves is engaged in the acquisition and development of oil and natural gas properties. The company owns and operates oil and natural gas producing properties located primarily in East Texas, the Permian Basin (West Texas and Southeast New Mexico), Rocky Mountain and Mid-Continent regions of the United States. The company is focused on two activities: the acquisition of producing oil and natural gas properties and the development of properties in established producing trends. As of Dec 31 2016, the company had proved reserves of 144.8 million barrels of oil equivalent, consisting of 32.5 million barrels of oil, 7.8 million barrels of natural gas liquids, and 627 billion cubic feet of natural gas.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.

PQ Group Holdings, through its wholly owned subsidiary, PQ Corporation, is a provider of catalysts, materials and chemicals, and services that enable environmental improvements, improve consumer products, and improve personal safety. The company has two reporting segments: Environmental Catalysts and Services, which is a producer of catalysts for the refinery, emission control, and petrochemical industries and is also a provider of catalyst recycling services to the refining industry; and Performance Materials and Chemicals, which serves end uses such as personal and industrial cleaning products, fuel efficient tires (green tires), surface coatings, and food and beverage.

Quanex Building Products manufactures components for original equipment manufacturers in the building products industry. The company's segments are: North American Fenestration, which focuses on the fenestration market in North America manufacturing vinyl profiles, insulating glass (IG) spacers, screens and other fenestration components; European Fenestration, comprising the company's United Kingdom-based vinyl extrusion business, manufacturing vinyl profiles and conservatories, and the European IG business manufacturing IG spacers; and North American Cabinet Components, comprising the company's North American cabinet door and components business and wood-manufacturing plants.

Resource Capital is a real estate investment trust. The company originates, holds and manages commercial mortgage loans and other commercial real estate-related debt investments. The company invests in the following asset classes: commercial real estate-related assets such as first mortgage loans, first priority interests in first mortgage loans, and subordinated interests in first mortgage loans; residential real estate-related assets such as residential mortgage loans and residential mortgage-backed securities; and commercial finance assets such as asset-backed securities, structured note investments, syndicated corporate loans, and preferred equity investment in a commercial leasing enterprise.

RiceBran Technologies is an ingredient company serving food, animal nutrition and specialty markets focused on processing and marketing of healthy, natural and nutrient dense products derived from raw rice bran, an underutilized by-product of the rice milling industry. The company converts raw rice bran into various products including: stabilized rice bran (SRB); RiBalance, a rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious, carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and its family of ProRyza products, which includes derivatives composed of protein and protein/fiber blends.

Schlumberger provides technology for reservoir characterization, drilling, production and processing to the oil and gas industry. The company has four segments: Reservoir Characterization, which consists of the principal technologies involved in finding and defining hydrocarbon resources; Drilling, which consists of the principal technologies involved in the drilling and positioning of oil and gas wells; Production, which consists of the principal technologies involved in the lifetime production of oil and gas reservoirs; and Cameron, which consists of the principal technologies involved in pressure and flow control for drilling and intervention rigs, oil and gas wells and production facilities.

SCYNEXIS is a biotechnology company. The company is engaged in developing its primary product candidate, ibrexafungerp, as an oral and intravenous triterpenoid antifungal family in clinical development for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. Ibrexafungerp is a structurally distinct glucan synthase inhibitor that has been shown in vitro and in vivo against a range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species.

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing ribonucleic acid-modulating drug candidates (designed to be eukaryotic ribosomal selective glycosides (ERSG)) that are formulated to treat rare and ultra-rare premature stop codon diseases. ELX-02, the company's primary investigational drug product candidate, is a small molecule designed to restore production of functional proteins. ELX-02, is in the early stages of clinical development for systemic administration for cystic fibrosis and cystinosis. The company's preclinical candidate pool consists of a library of 170 ERSG drug candidates identified based on read-through potential and cytoplasmic ribosomal selectivity.

SmartFinancial is a bank holding company. Through its subsidiary, SmartBank, the company accepts deposits from the general public and invests those funds, together with funds generated from operations and from principal and interest payments on loans, primarily in commercial loans, commercial and residential real estate loans, consumer loans and residential and commercial construction loans. The company's primary deposit products are interest-bearing demand deposits, savings and money market deposits, and time deposits. The company's loan portfolio segments include commercial real estate, consumer real estate, construction and land development, commercial and industrial, and consumer and other.

Stellus Capital Investment is an externally managed, closed-end, non-diversified management investment company. The company's investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments in middle-market companies.

StoneMor Partners is a provider of funeral and cemetery products and services in the death care industry. The company's segments include: Cemetery Operations, which include sales of cemetery interment rights, merchandise and services and the performance of cemetery maintenance and other services; and Funeral Homes Operations, which provides a range of services, including family consultation, final expense insurance products, the removal and preparation of remains, provision of caskets and related funeral merchandise, the use of funeral home facilities for visitation, worship and performance of funeral services and transportation services.

Trinity Industries is a provider of railcar products and services in North America. The company has the following reportable segments: Railcar Leasing and Management Services Group, which provides operating leases for freight and tank railcars, as well as originates and manages railcar leases for third-party investors and provides fleet maintenance and management services to industrial shippers; Rail Products Group, which manufactures freight and tank railcars in North America used for transporting a variety of liquids, gases, and dry cargo, and also provides a range of maintenance services and solutions; and All Other, which includes the company's highway products business.

United Airlines Holdings is a holding company and its principal, wholly-owned subsidiary is United Airlines, Inc. (United). The company is engaged in the transportation of people and cargo throughout North America and to destinations in Asia, Europe, Africa, the Pacific, the Middle East and Latin America. The company, through United and its regional carriers, operates flights to airports, with its hubs at Newark Liberty International Airport, Chicago O'Hare International Airport, Denver International Airport, George Bush Intercontinental Airport, Los Angeles International Airport, A.B. Won Pat International Airport, San Francisco International Airport and Washington Dulles International Airport.

Veritone is a provider of artificial intelligence (AI) computing solutions. The company has developed aiWARE?, a proprietary AI operating system that integrates and orchestrates an open ecosystem of performing cognitive engines. The company'saiWARE platform incorporates proprietary technology to integrate and intelligently orchestrate a variety of cognitive engine capabilities to mimic human cognitive functions. The company also operates a full service media advertising agency. The company's services include media planning and strategy, advertisement buying and placement, campaign messaging, clearance verification and attribution, and custom analytics.